We describe a "high-performance" reversed-phase liquidchromatographic method for determination of indole-3-acetic acid (I) and 5-hydroxyindole-3-acetic acid (II) in human plasma. I is eluted at 1.0 mL/min with a mixture of 1-pentanesulfonic acid (pH 3.1), methanol, and water. It is detected by fluorometry. A mixture of citric acid/sodium phosphate solution (pH 4.8) and methanol, at 1.5 mL'min, is used to elute II, which is detected with an electrochemical cell. Platelet-poor plasma samples were pretreated with HCI, perchloric acid, and trichloroacetic acid for protein precipitation. Best results were obtained with the last (protein precipitation is incomplete with HCI, while recoveries of I are concentration dependent with perchloric acid). Analytical recoveries were 58% (SD 3.1%, CV 5.3%, n = 12) and 79% (SD 3.3%, CV 5.3%, n = 9) for I and II, respectively. Concentrations of I and II in plasma ranged from 0.61 to 3.32 (mean 1.54, SD 0.59, n = 15) mol/L and from 33.0 to 102.6 (mean 51.8, SD 20.1, n = 16) nmol/L, respectively. 
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The metabolism of 5-hydroxytryptamine has been implicated in the etiology of psychiatric disorders such as depressive states (1) as well as in other neurological alterations (for a review, see 2). Also, alterations of 5-hydroxytryptamine metabolism have been described in the carcinoid syndrome (3) as well in several types of cancer (4 (6) .
The behaviorally-active trace amine, tryptamine, is produced in mammals through decarboxylation of tryptophan, a common precursor of both amines. At present, several lines of evidence suggest a possible neuromodulator activity of tryptamine in the central nervous system (7) (8) (9) 
Materials and Methods

Reagents
All chemicals were of analytical grade. Methanol used as chromatographic eluent was "HPLC" grade.
Standards
Stock 1.0 g/L solutions of 5HIAA and IAA (Sigma Chemical Co., St. Louis, MO 63178) were prepared weekly in isotonic saline and stored at 4#{176}C. Working standards were freshly prepared by diluting stock solutions. 
Apparatus
We used a M6000 solvent-delivery system with an automatic sample injector (WISP 710B; Waters Associates
Inc., For chromatographic analysis with fluorometric detection we used a mobile phase consisting of an equivolume mixture of 1-pentanesulfomc acid (PlC B-5, Waters Assoc.) 5 mmoli L, pH 3.1, and methanol/water (7/3 by vol), at a flow rate of 1.0 mL/min. Excitation and emission wavelengths were set at 280 nm and 340 nm, respectively.
When the electrochemical detector was used, the mobile phase consisted of a 94/6 (by vol) mixture (pH 4.8) of citric acid 30 mmolJL), disodium hydrogen phosphate (60 mmol/L) and methanol, at a flow rate of 1.5 mL/min. The potential of the glassy carbon electrode was set to 0.55 V vs the Ag/AgCl reference electrode.
Plasma Samples
Blood was sampled from ostensibly healthy adult volunteers who had fasted overnight.
Samples were drawn by venipuncture at 0900 hours into polypropylene tubes containing EDTA in saline (5.0 g/L; one vol per three vol of blood). The contents of the tubes were gently mixed by several inversions. PPP samples were obtained by centrifuging the whole blood (1000 x g, 10 mm, 4 #{176}C). The supernates were carefuly removed and stored at -40 #{176}C until analyzed.
For methodological studies we used a single specimen of plasma, corresponding to 100 mL of blood from one donor. Run the chromatographic analyses at room temperature.
Quantification
PPP samples were supplemented with the appropriate amounts of IAA or 5HLAA (see results) and subjected to the procedure described above. The endogenous 5HIAA or IAA in plasma was calculated in each sample by comparing peak heights of the corresponding "endogenous" and "supplemented" aliquots.
Results
Both acid metabolites, IAA and 5HIAA, were chromatographed on the same reversed-phase column, as described in the previous section. However, the choice of the most suitable detector system was based in each case on the sensitivity of response needed to work within the physiological working range. For instance, a few picograms of 5HIAA can readily be detected by an electrochemical cell operated at 0.5-0.7 V (18, 19) . In contrast, detection of IAA would require a relatively higher electrochenucal detector electrode potential, which in turn would generate a high inter- However, HC1 was unsatisfactory, especially for a mobile phase containing 50% methanol; column filters become clogged with protein, column pressure increases, and resolution becomes poor. In fact, after no more than 10 injections, chromatographic performance was appreciably degraded. The HC1 procedure would contribute to preventing losses of IAA through its possible occlusion by the precipitating proteins, thus facilitating the quantitative assay by external calibration, but it would not be useful in practice for the above reasons. The mean value obtained in this way for five determinations of the plasma sample used for calibration of the method was 1.25 (SD 0.04) mol/L.
To obviate this problem, we removed plasma proteins by precipitation with either PCA or TCA. The advantages of either one of these deproteinizing agents in the assay of IAA in human plasma were evaluated as follows. Twelve 2O0-tL samples of donor's PPP were each supplemented
. with increasing amounts of authentic IAA (final concentration of added IA.A: 0.38 to 3.77 MmoIfL), thus obtaining four groups of three samples each. These were assayed by HPLC after protein precipitation with either PCA or TCA. For plasma samples treated with PCA, the CV of each of the replicate data points was 3.2%. The points lay along a straight line defined by the intercept and slope included in Figure 2A . The corresponding correlation coefficient was r2 = .9990 and the experimentally measured endogenous IAA peak height was 66.6 units, in agreement with the calculated value of 65.4 (see intercepts in Figure 2A ). Figure 2A also shows the regression line corresponding to IAA standard solutions treated as plasma samples, and run in duplicate.
The calculated average recovery for the four different concentrations of IAA (n = 12) was 25.8 (SD 5.7), the CV 22%. However, recovery was found to depend on the concentration of IAA. It increased in parallel with the amount added, On the other hand, plasma samples treated with TCA gave a straight line, the CV being 2.3% for each of the triplicate measurements. In this case, the regression equation is as shown in Figure 2B . The measured LAA peak height in the chromatogram of the unsupplemented sample was 81.3. Similarly, standard solutions of increasing concentrations of IAA, each treated with TCA as with actual plasma samples, gave a straight line ( Figure 2B ) intersecting the x-axis at 65 fmol of IAA, equivalent to 11.4 pg. The mean recovery improved in this case to 58% with SD = 3.1 and CV = 5.3% for n = 12 and, in contrast to the variation observed when PCA was used, the recovery values for different IAA concentrations in plasma are similar within the working range 0.38-3.77 j.tmol/L (Table 2) .
Our results nevertheless prove that there are no degradative losses with either TCA or PCA, as shown by the regression data corresponding to the standard solutions. Furthermore, washing the PCA or TCA protein precipitate does not increase recoveries by more than 15% at most, whereas the additional dilution decreases the concentration of the acids in the samples, thus diminishing sensitivity. 5HIAA ( Figure 1B) was assayed in the same way, with recoveries in this case of 78.8% (SD 3.3% and CV 4.2%). The values observed for both acids are given in Table 3 . Interferences due to other related compounds also present in plasma samples are ruled out by their significantly different retention volumes (Table 1) . Furthermore, the reproducibility of the retention data is excellent, as shown also in this table for both acids, contributing further to the reliability of the method.
A significant correlation (p < .05, n = 16) was found between body weight and the concentration of 5HIAA in plasma.
The observed values for both acids differ by a factor of 30, IAA being greater than 5HIAA. This is interesting, because IAA is the principal metabolite of tryptamine, and no clear physiological or pathological roles have yet been found for it.
Work is in progress to determine the significance of this relatively high IAA concentration in human plasma for healthy volunteers.
